Brasier, Allan – ICTR – UW–Madison

$ 21.50

4.8
(633)
In stock
Description

Allan BRASIER, Executive Director, University of Wisconsin–Madison, Wisconsin, UW, Institute for Clinical and Translational Research

Dr. Allan Brasier arrives to lead translational research efforts at UW- Madison

Frontiers Selective Inhibition of Bromodomain-Containing Protein 4 Reduces Myofibroblast Transdifferentiation and Pulmonary Fibrosis

Allan BRASIER, Executive Director, University of Wisconsin–Madison, Wisconsin, UW, Institute for Clinical and Translational Research

WARF Therapeutics kicks off with campus forum - WARF

Drug Hunter” Jon Young draws on industry roots to lead WARF Therapeutics - WARF

Frontiers Selective Inhibition of Bromodomain-Containing Protein 4 Reduces Myofibroblast Transdifferentiation and Pulmonary Fibrosis

D&I Launchpad Studies Formation of Academic-Private Partnerships During COVID19 – ICTR – UW–Madison

Savannah Snyder on LinkedIn: #proteomics #clinicalproteomics #conference #research #biotechnology…